Biologics 101

Biologics 101

In the first of three webinars on biologics, Sandy Johnson talked with Ed Silverman, Pharmalot writer with The Boston Globe’s Stat, and Dr. Kathryn C. Zoon, chief of Cytokine Biology in the NIAID, a branch of the National Institutes of Health.

Regulation & Prevalence of Bio-Tech Drugs

Regulation & Prevalence of Bio-Tech Drugs

Patricia Zettler, associate chief counsel at FDA for four years and now an associate law professor at Georgia State University, and Sarah Karlin, POLITICO Pro health care reporter.

What’s Next? Biosimilars

What’s Next? Biosimilars

Michael Kleinrock, director of research development for IMS Institute For Healthcare Informatics and Dr. Jeremy Greene of Johns Hopkins University

Highlights:  Future of Biosimilar Drugs

Highlights: Future of Biosimilar Drugs

Highlights from What's Next? Biosimilars: The Future of Biosimilar Drugs in the U.S

Highlights: Regulatory Process

Highlights: Regulatory Process

video highlights with  Patricia Zettler, associate chief counsel at FDA for four years and now an associate law professor at Georgia State University, and Sarah Karlin, POLITICO Pro health care reporter.